Clinical trial Recruiting at 1 site Observational Ages 18 to 75

NIRS and BIS monitoring during cerebral aneurysm coiling under anesthesia

Official title: Evaluation of Near-Infrared Spectroscopy and Bispectral Index Monitoring During Cerebral Aneurysm Coil Embolization

Run by Dokuz Eylul University · NCT07438275 · Data updated 2026-11-12

This study tests whether continuous NIRS and BIS monitoring during endovascular aneurysm coiling under general anesthesia can help identify cerebral desaturation and its relationship to anesthetic depth and blood flow.

More Cerebral Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment75 (estimated)
SponsorDokuz Eylul University
Academic / other
Locations1 site (Gaziantep)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedNovember 1, 2026
Study endsDecember 2026
Registry record updatedOctober 21, 2026
Trial IDNCT07438275 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with intracranial aneurysms scheduled for endovascular coil embolization under general anesthesia, ASA I–III, able to consent.

Probably not a fit

Patients with contraindications to NIRS/BIS or emergency procedures may not benefit from the monitoring approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study will monitor adults undergoing endovascular coil embolization for cerebral aneurysms with near-infrared spectroscopy (NIRS) and bispectral index (BIS) alongside standard anesthesia monitoring. Baseline rSO₂ and BIS will be recorded before induction, with ongoing measurements during the procedure to identify cerebral desaturation (defined as a ≥20% drop in rSO₂). The study will analyze associations between NIRS readings, BIS values, and hemodynamic parameters to understand multimodal neuromonitoring in neuroendovascular procedures. No additional interventions beyond routine monitoring will be performed. The goal is to inform clinical decision-making for cerebral protection during endovascular treatment.

Why it matters

Potential benefit: If successful, this approach could improve detection of cerebral desaturation and guide intraoperative management to reduce ischemic risk.

How similar studies have gone: Previous studies have used NIRS and BIS separately in neurosurgical settings; combined multimodal monitoring in this exact context is promising but not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Age ≥18 years
* Patients scheduled for endovascular coil embolization for intracranial (cerebral) aneurysm
* American Society of Anesthesiologists (ASA) physical status I-III
* Undergoing the procedure under general anesthesia
* Ability to provide written informed consent Criteria

Exclusion Criteria:

* Refusal or inability to provide informed consent
* History of severe cerebrovascular disease other than the target aneurysm
* Severe cardiac, pulmonary, hepatic, or renal dysfunction
* Pre-existing neurological deficits interfering with NIRS or BIS interpretation
* Known scalp or skin conditions preventing proper placement of NIRS or BIS sensors
* Emergency procedures
* Pregnancy -

Where it's running

  • Gülay Akıncı
    Gaziantep, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Investigating factors related to intracranial aneurysms in China

    This study looks at what factors might cause or worsen brain aneurysms in people in China to help understand the risks better.

    Recruiting Zhujiang Hospital · Guangzhou · NCT06456814

  • Real-world outcomes of MicroVention devices for intracranial aneurysm treatment

    This project collects real-world data to see how well commercially available MicroVention devices work for treating brain aneurysms in patients treated by their doctors.

    Recruiting at 27 sites Microvention-Terumo, Inc. · Walnut Creek, California and 26 other locations · NCT06215105

  • Evaluating flow-diverting stents for treating cerebral aneurysms

    This study is testing two types of stents to see if they can safely and effectively treat cerebral aneurysms in patients across several hospitals in Spain.

    Recruiting at 11 sites Hospital Universitario Central de Asturias · A Coruña and 10 other locations · NCT06201598

  • Registry of brain-heart comorbidity in China

    This study is trying to build a big database to better understand and manage the connection between brain and heart problems in people across China.

    Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality and 13 other locations · NCT05961748

  • Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates

    A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.

    Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre · Montreal, Quebec · NCT07732244

  • Risk factors for rupture of flow-related aneurysms in posterior brain AVMs

    This project tries to find which clinical and imaging features make flow-related aneurysms in posterior brain arteriovenous malformations more likely to rupture in people with subarachnoid hemorrhage.

    Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu and 1 other locations · NCT07050381

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.